SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-21-006591
Filing Date
2021-06-04
Accepted
2021-06-04 10:17:16
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brac-sch13d_a5882423.htm SC 13D/A 167484
2 MERGER AGREEMENT, DATED AS OF DECEMBER 13, 2020, BY AND AMONG BIG ROCK PARTNERS brac_ex10.htm EX-10 954147
3 SPONSOR AGREEMENT, DATED AS OF MAY 24, 2021, BY AND AMONG BIG ROCK PARTNERS ACQU brac_ex11.htm EX-11 27675
4 AMENDMENT TO STOCK ESCROW AGREEMENT, DATED AS OF MAY 24, 2021, BY AND AMONG BIG brac_ex12.htm EX-12 69435
5 BCMA AMENDMENT, DATED AS OF MAY 24, 2021, BY AND BETWEEN BIG ROCK PARTNERS ACQUI brac_ex13.htm EX-13 21214
  Complete submission text file 0001654954-21-006591.txt   1241662
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Subject) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90195 | Film No.: 21995283
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DAVID NUSSBAUM EARLYBIRDCAPITAL, INC 366 MADISON AVE, 8TH FL NEW YORK NY 10017
Business Address C/O DAVID NUSSBAUM EARLYBIRDCAPITAL, INC 366 MADISON AVE, 8TH FL NEW YORK NY 10017 2126610200
BRAC Lending Group LLC (Filed by) CIK: 0001759828 (see all company filings)

IRS No.: 832531762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A